Kenneth L. Cox

Publications

• Geographical rural status and health outcomes in pediatric liver transplantation: an analysis of 6 years of national United Network of Organ Sharing Data. Park KT, Bensen R, Lu B, Nanda P, Esquivel C, Cox K. J Pediatr. 2013; 162 (2): 313-8.e1
• Immunomodulatory effect of vancomycin on Treg in pediatric inflammatory bowel disease and primary sclerosing cholangitis. Abarbanel DN, Seki SM, Davies Y, Marlen N, Benavides JA, Cox K, Nadeau KC, Cox KL. J Clin Immunol. 2013; 33 (2): 397-406
• Markers of antigen presentation and activation on eosinophils and T cells in the esophageal tissue of patients with eosinophilic esophagitis. Le-Carlson M, Seki S, Abarbanel D, Quiros A, Cox K, Nadeau KC. J Pediatr Gastroenterol Nutr. 2013; 56 (3): 257-62
• A common peripheral blood gene set for diagnosis of operational tolerance in pediatric and adult liver transplantation. Li L, Wozniak LJ, Rodder S, Heish S, Talisetti A, Wang Q, Esquivel C, Cox K, Chen R, McDiarmid SV, Sarwal MM. Am J Transplant. 2012; 12 (5): 1218-28
• Effects of rural status on health outcomes in pediatric liver transplantation: a single center analysis of 388 patients. Park KT, Nanda P, Bensen R, Strichartz D, Esquivel C, Cox K. Pediatr Transplant. 2011; 15 (3): 300-5
• Immunophenotyping of peripheral eosinophils demonstrates activation in eosinophilic esophagitis. Nguyen T, Gernez Y, Fuentebella J, Patel A, Tirouvanziam R, Reshamwala N, Bass D, Berquist WE, Cox KL, Kerner JA, Nadeau KC. J Pediatr Gastroenterol Nutr. 2011; 53 (1): 40-7
• Analysis of clinical variables associated with tolerance in pediatric liver transplant recipients. Talisetti A, Hurwitz M, Sarwal M, Berquist W, Castillo R, Bass D, Concepcion W, Esquivel CO, Cox K. Pediatr Transplant. 2010; 14 (8): 976-9
• Eotaxin and FGF enhance signaling through an extracellular signal-related kinase (ERK)-dependent pathway in the pathogenesis of Eosinophilic esophagitis. Huang JJ, Joh JW, Fuentebella J, Patel A, Nguyen T, Seki S, Hoyte L, Reshamwala N, Nguyen C, Quiros A, Bass D, Sibley E, Berquist W, Cox K, Kerner J, Nadeau KC. Allergy Asthma Clin Immunol. 2010; 6 (1): 25
• Expression of soluble HLA-G identifies favorable outcomes in liver transplant recipients. Zarkhin V, Talisetti A, Li L, Wozniak LJ, McDiarmid SV, Cox K, Esquivel C, Sarwal MM. Transplantation. 2010; 90 (9): 1000-5
• Increased HLA-DR expression on tissue eosinophils in eosinophilic esophagitis. Patel AJ, Fuentebella J, Gernez Y, Nguyen T, Bass D, Berquist W, Cox K, Sibley E, Kerner J, Nadeau K. J Pediatr Gastroenterol Nutr. 2010; 51 (3): 290-4
• Increased number of regulatory T cells in children with eosinophilic esophagitis. Fuentebella J, Patel A, Nguyen T, Sanjanwala B, Berquist W, Kerner JA, Bass D, Cox K, Hurwitz M, Huang J, Nguyen C, Quiros JA, Nadeau K. J Pediatr Gastroenterol Nutr. 2010; 51 (3): 283-9
• Decreases in circulating CD4+CD25hiFOXP3+ cells and increases in intragraft FOXP3+ cells accompany allograft rejection in pediatric liver allograft recipients. Stenard F, Nguyen C, Cox K, Kambham N, Umetsu DT, Krams SM, Esquivel CO, Martinez OM. Pediatr Transplant. 2009; 13 (1): 70-80
• Long-term treatment of primary sclerosing cholangitis in children with oral vancomycin: an immunomodulating antibiotic. Davies YK, Cox KM, Abdullah BA, Safta A, Terry AB, Cox KL. J Pediatr Gastroenterol Nutr. 2008; 47 (1): 61-7
• Non-adherence to post-transplant care: prevalence, risk factors and outcomes in adolescent liver transplant recipients. Berquist RK, Berquist WE, Esquivel CO, Cox KL, Wayman KI, Litt IF. Pediatr Transplant. 2008; 12 (2): 194-200
• Outcomes of transplantation in children with primary hepatic malignancy. Beaunoyer M, Vanatta JM, Ogihara M, Strichartz D, Dahl G, Berquist WE, Castillo RO, Cox KL, Esquivel CO. Pediatr Transplant. 2007; 11 (6): 655-60
• Pediatric intestinal transplantation at Packard Children's Hospital/Stanford University Medical Center: report of a four-year experience. Castillo RO, Zarge R, Cox K, Strichartz D, Berquist W, Bonham CA, Esquivel CO. Transplant Proc. 2006 Jul-Aug; 38 (6): 1716-7
• Adolescent non-adherence: prevalence and consequences in liver transplant recipients. Berquist RK, Berquist WE, Esquivel CO, Cox KL, Wayman KI, Litt IF. Pediatr Transplant. 2006; 10 (3): 304-10
• Hepatic infantile hemangioendothelioma with unusual manifestations. Riley MR, Burtelow M, Garcia MG, Garcia M, Lucile S, Cox KL, Cox K, Berquist WE, Berquist W, Kerner JA, Kemer J. J Pediatr Gastroenterol Nutr. 2006; 42 (1): 109-13
• Improved pain management in pediatric postoperative liver transplant patients using parental education and non-pharmacologic interventions. Sharek PJ, Wayman K, Lin E, Strichartz D, Sentivany-Collins S, Good J, Esquivel C, Brown M, Cox K. Pediatr Transplant. 2006; 10 (2): 172-7
• Complete immunosuppressive withdrawal as a uniform approach to post-transplant lymphoproliferative disease in pediatric liver transplantation. Hurwitz M, Desai DM, Cox KL, Berquist WE, Esquivel CO, Millan MT. Pediatr Transplant. 2004; 8 (3): 267-72
• One hundred percent patient and kidney allograft survival with simultaneous liver and kidney transplantation in infants with primary hyperoxaluria: a single-center experience. Millan MT, Berquist WE, So SK, Sarwal MM, Wayman KI, Cox KL, Filler G, Salvatierra O, Esquivel CO. Transplantation. 2003; 76 (10): 1458-63
• Identification of Epstein-Barr virus-specific CD8+ T lymphocytes in the circulation of pediatric transplant recipients. Falco DA, Nepomuceno RR, Krams SM, Lee PP, Davis MM, Salvatierra O, Alexander SR, Esquivel CO, Cox KL, Frankel LR, Martinez OM. Transplantation. 2002; 74 (4): 501-10
• Thirteen years' experience in pediatric liver transplantation: differences between tacrolimus and cyclosporine. Zajicek A, Esquivel C, Millan M, Cox K, Berquist R, Berquist W. Transplant Proc. 2002; 34 (5): 1976-8
• Mortality rate correlated with the number of pediatric liver transplants performed at a center. Cox K, Rodriguez-Baez N, Nasr A, Esquivel C. Transplant Proc. 2001 Feb-Mar; 33 (1-2): 1512-3
• Gastrointestinal dysfunction associated with syringomyelia and hydromyelia. Garcia-Careaga M, Cox KM, Blankenberg F, Cox KL. J Pediatr Gastroenterol Nutr. 2000; 31 (1): 71-5
• Significance of detecting Epstein-Barr-specific sequences in the peripheral blood of asymptomatic pediatric liver transplant recipients. Krieger NR, Martinez OM, Krams SM, Cox K, So S, Esquivel CO. Liver Transpl. 2000; 6 (1): 62-6
• Paediatric liver transplantation: indications, timing and medical complications. Cox KL, Berquist WE, Castillo RO. J Gastroenterol Hepatol. 1999: 14 Suppl S61-6
• Increased dosage requirement and rejection after Neoral conversion in pediatric liver transplant patients. Cao S, Cox KL, Berquist W, So S, Concepcion W, Monge H, Esquivel CO. Transplant Proc. 1998; 30 (8): 4322-4
• Liver transplantation at Stanford University Medical Center. Millan MT, Keeffe EB, Berquist WE, Castillo RO, Cox KL, Garcia G, Imperial JC, Monge H, So SK, Esquivel CO. Clin Transpl. 1998: 287-96
• Oral vancomycin: treatment of primary sclerosing cholangitis in children with inflammatory bowel disease. Cox KL, Cox KM. J Pediatr Gastroenterol Nutr. 1998; 27 (5): 580-3
• Epstein-Barr virus lymphoproliferative disorders after liver transplantation. Cao S, Cox KL. Clin Liver Dis. 1997; 1 (2): 453-69, x-xi